NextEra Energy Rallies Despite Big, Beautiful Bill's Blow to Clean Energy: Is the Stock Still a Buy?
The Motley Fool· 2025-08-27 00:13
While clean energy has been battered by recent legislation, NextEra Energy stock has been on the rise.President Donald Trump on July 4 signed into law the "big, beautiful bill," which rolls back over $200 billion in clean energy tax credits, in a move some have described as a "disaster" for the clean energy industry.Florida-based utility company NextEra Energy (NEE -0.54%), which provides 12 million people with electricity and is America's largest provider of clean energy, stands to lose potentially hundred ...
MongoDB Q2 FY2025 Earnings Call Transcipt
Benzinga· 2025-08-26 23:35
MongoDB, Inc. MDB released its second-quarter financial results after Tuesday’s closing bell.Below are the transcripts from the second quarter earnings call.This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation.MDB stock is up after hours on Tuesday. Get the details here.OPERATORGood day everyone and welcome to MongoDB’s second quarter fiscal year 2026 earnings call. @ this time all participants are in a ...
Fountain Asset Corp. Announces Its Financial Results for the Quarter Ended June 30, 2025
Globenewswire· 2025-08-26 23:26
Core Viewpoint - Fountain Asset Corp. reported strong financial results for Q2 and the first half of 2025, highlighting significant gains in investment activities and an increase in net asset value [1][6]. Summary of Financial Results for Q2/25 - The company realized $0.47 million in gains from the sale of portfolio investments, driven by increased trading prices in the technology sector [4]. - Net assets as of June 30, 2025, were valued at $8.59 million, or $0.13 per share, up from $5.51 million, or $0.09 per share, at the end of 2024, representing a 44% increase [5][8]. - Net comprehensive income for Q2/25 was $3.01 million, compared to a net comprehensive loss of $0.49 million for Q2/24 [8]. Summary of Financial Results for Six Months Ended June 30, 2025 - For the six months ended June 30, 2025, net comprehensive income was $3.06 million, compared to a net comprehensive loss of $0.95 million for the same period in 2024 [8]. - Total income from investment activities was $3.65 million, contrasting with a total loss of $0.54 million for the first half of 2024 [8]. - Net realized gains on the sale of portfolio investments reached $1.76 million, compared to net realized losses of $0.14 million for the same period in 2024 [8]. - Net unrealized gains on portfolio investments were $1.82 million, compared to net unrealized losses of $0.41 million for the first half of 2024 [8]. - Total expenses for the six months were $0.58 million, up from $0.40 million in the same period of 2024, while operating expenses decreased to $0.29 million from $0.39 million [8]. Company Overview - Fountain Asset Corp. operates as a merchant bank, providing equity financing, bridge loan services, and strategic financial consulting across various industries, including marijuana, oil & gas, mining, real estate, manufacturing, retail, financial services, and biotechnology [7].
Lennar (LEN) Stock Falls Amid Market Uptick: What Investors Need to Know
ZACKS· 2025-08-26 23:16
Company Overview - Lennar's stock closed at $133.27, reflecting a -1.14% change from the previous day's closing price, underperforming the S&P 500 which gained 0.41% [1] - Over the past month, Lennar's stock has increased by 16.07%, outperforming the Construction sector's gain of 1.31% and the S&P 500's gain of 0.87% [1] Earnings Forecast - The upcoming earnings release is anticipated, with an expected EPS of $2.14, indicating a 45.13% decline from the same quarter last year [2] - Revenue is projected at $9.07 billion, reflecting a 3.7% decrease from the equivalent quarter last year [2] Annual Estimates - For the annual period, earnings are estimated at $9.04 per share and revenue at $35.22 billion, representing declines of -34.78% and -0.63% respectively from the previous year [3] Analyst Estimates - Recent changes in analyst estimates are crucial for understanding business trends, with positive revisions indicating optimism about the business outlook [3][4] - The Zacks Rank system, which incorporates estimate changes, provides actionable ratings, with Lennar currently holding a Zacks Rank of 5 (Strong Sell) [5] Valuation Metrics - Lennar's Forward P/E ratio is 14.91, which is higher than the industry average of 11.84 [6] - The PEG ratio for Lennar is 5.72, compared to the industry average of 2.59, indicating a premium valuation relative to expected earnings growth [6] Industry Context - The Building Products - Home Builders industry is ranked 228 in the Zacks Industry Rank, placing it in the bottom 8% of over 250 industries [7] - The Zacks Industry Rank measures the strength of industry groups, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [7]
SNAP INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Snap Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire News Room· 2025-08-26 23:15
Core Viewpoint - The Snap Inc. class action lawsuit alleges that the company and its executives misled investors regarding advertising revenue and growth expectations, leading to significant financial losses for shareholders during the specified class period [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Abdul-Hameed v. Snap Inc., No. 25-cv-07844 (C.D. Cal.), and it involves purchasers of Snap securities from April 29, 2025, to August 5, 2025 [1]. - Investors have until October 20, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit claims that Snap's executives created a false impression of reliable advertising revenue information while downplaying macroeconomic instability [3]. Group 2: Allegations Against Snap - The lawsuit alleges that Snap's optimistic reports on advertising growth were misleading and did not reflect the company's actual performance, which was impacted by execution errors [3]. - On August 5, 2025, Snap reported disappointing second-quarter results, revealing a significant deceleration in advertising revenue, which caused the stock price to drop over 17% [4]. Group 3: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Snap securities during the class period to seek lead plaintiff status [5]. - The lead plaintiff represents the interests of all class members and can choose a law firm to litigate the case [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [6].
Summary Notice of Proposed Settlement of Derivative Matters
Globenewswire· 2025-08-26 23:14
Core Points - A federal court has authorized a settlement regarding a derivative lawsuit involving Okta, Inc., which will include the adoption of corporate governance reforms [1][2] - The settlement is deemed fair and reasonable by the Settling Parties, and it is expected to benefit both the company and its stockholders [2] - A fee of $2,250,000 for attorneys' fees and expenses has been agreed upon, which the Settling Defendants will not oppose [3] Settlement Hearing - A Settlement Hearing is scheduled for October 24, 2025, where the court will evaluate the fairness and adequacy of the settlement [4] - Current Okta stockholders have the option to appear at the hearing and voice objections, but must follow specific procedures to do so [5][6] - Written objections must be filed with the court at least 14 days prior to the hearing to be considered [7][8] Additional Information - The Stipulation and its details can be accessed on Okta's Investor Relations page [9] - Inquiries regarding the settlement should be directed to Settling Stockholders' Counsel, not the court [10]
UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals
Globenewswire· 2025-08-26 23:12
Core Viewpoint - Catalyst Pharmaceuticals and SERB have reached a settlement with Lupin regarding the patent litigation over FIRDAPSE, allowing Lupin to market a generic version starting February 25, 2035, if approved by the FDA [1][2]. Group 1: Settlement Agreement Details - The settlement prohibits Lupin from marketing its generic version of FIRDAPSE in the U.S. before February 25, 2035, unless specific circumstances arise [2]. - All ongoing patent litigation between Catalyst/SERB and Lupin concerning FIRDAPSE patents will be terminated as part of the agreement [2]. - Catalyst has previously settled similar litigation regarding ANDA applications for FIRDAPSE with Teva Pharmaceuticals and Inventia Healthcare Limited [2]. Group 2: Company Overview - Catalyst Pharmaceuticals is focused on developing and commercializing treatments for rare diseases and has a strong commitment to patient care [4]. - The company has been recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [4].
Alphabet Lands $10B Meta Cloud Deal--Is A Siri-Gemini Deal Close?
Seeking Alpha· 2025-08-26 23:11
I'm a full time value investor and writer who enjoys using classical value ratios to pick my portfolio. My previous working background is in private credit and CRE mezzanine financing for a family office. I'm also a fluent Mandarin speaker in both business and court settings, previously serving as a court interpreter. I have spent a good chunk of my adult working life in China and Asia. I have worked with top CRE developers in the past including The Witkoff Group , Kushner Companies, Durst Organization and ...
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
Globenewswire· 2025-08-26 23:00
Core Insights - MediciNova, Inc. has successfully enrolled the target number of participants in its COMBAT-ALS Phase 2b/3 clinical trial for MN-166 (ibudilast), aimed at treating Amyotrophic Lateral Sclerosis (ALS) [1][2] Company Overview - MediciNova is a clinical-stage biopharmaceutical company focused on developing novel small molecule therapies for inflammatory, fibrotic, and neurodegenerative diseases, with a pipeline that includes 11 clinical programs [4] - The lead asset, MN-166 (ibudilast), is in late-stage clinical development for ALS and other neurodegenerative conditions, and is also being evaluated for Long COVID and substance dependence [4] Product Details - MN-166 (ibudilast) is a small molecule that inhibits phosphodiesterase type-4 (PDE4) and inflammatory cytokines, and is being developed for various conditions including ALS, progressive multiple sclerosis, and glioblastoma [3] - The COMBAT-ALS study has enrolled participants across multiple sites in the US and Canada, indicating a broad collaborative effort [2]
South Star Announces Indicative Term Sheet for US$4M Debt Financing for the Santa Cruz Graphite Mine in Brazil and Appointment of New CFO
Globenewswire· 2025-08-26 23:00
Core Viewpoint - South Star Battery Metals Corp has signed a non-binding indicative term sheet for a US$4,000,000 loan facility with Sprott Streaming to support the development of the Phase 1 Santa Cruz Graphite Mine in Brazil [1][6]. Loan Details - The loan has a maturity of 3 years, with the initial tranche of US$200,000 contingent on US$2,000,000 equity or subordinated debt financing [1][4]. - The loan proceeds will be exclusively used for equipment adjustments, working capital, and process optimization at the Santa Cruz Graphite Mine, aiming for a production ramp-up from 450 tonnes per month to 1,000 tonnes per month [2][6]. - The loan will have an interest rate of 12% per annum for the first 24 months, increasing to 18% for the final 12 months, with a 12-month grace period [4]. Management Commentary - The CEO of South Star expressed satisfaction with the financing partnership with Sprott Streaming, highlighting the importance of this facility for advancing the Santa Cruz Graphite Mine and enhancing the company's position as a critical materials supplier for the energy transition [3][6]. Financial and Operational Strategy - A detailed development plan has been prepared to improve operational performance and ensure consistent product quality at Santa Cruz [2]. - The loan will enhance operational robustness and provide financial flexibility for executing the development plan [2]. Leadership Changes - Mr. Darren Prins has been appointed as the new Chief Financial Officer, bringing over 20 years of experience in finance and accounting [5][7]. - The CEO welcomed Mr. Prins to the team, emphasizing the value of his extensive experience in senior finance roles [8]. Company Overview - South Star is focused on developing battery-metals projects in the Americas, with the Santa Cruz Graphite Project being the first of its kind in the region since 1996 [9]. - The company is also advancing the BamaStar Project in Alabama, which has shown strong economic results in preliminary assessments [10]. ESG Commitment - South Star is committed to high standards of ESG principles, emphasizing transparency, stakeholder engagement, and stewardship in its operations [11].